Owner
Post by Franko10 ™ on Jan 18, 2005 11:08:06 GMT -5
Diagem Inc.: Private Placements
10:45 EST Tuesday, January 18, 2005
MONTREAL, QUEBEC--(CCNMatthews - Jan. 18, 2005) - DIAGEM INC. (the "Company" or "Diagem") (TSX VENTURE:DGM) announces that it will undertake non brokered private placements of up to $2 million of units at $0.20 each. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share of the Company at a price of $0.23 per share for a period of twenty-four months following the closing. Insiders of the Company will participate in these private placements.
Diagem also announces that it has granted a total of 3,150,000 options to purchase common shares in the Company to its directors and 1,050,000 options to purchase common shares to officers who are not directors of the Company. In addition, 750,000 options to purchase common shares have been granted to employees and a consultant of its Brazilian subsidiary. All options have an exercise price of $0.20 and an exercise period of five years.
For and on behalf of
DIAGEM INC.
"Mousseau Tremblay", Chairman and CEO
FOR FURTHER INFORMATION PLEASE CONTACT:
Diagem Inc.
Mousseau Tremblay
Chairman and CEO
(514) 866-6001 / (613) 347-2561
(514) 866-6193 (FAX)
Website: www.diagem.com
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.
10:45 EST Tuesday, January 18, 2005
MONTREAL, QUEBEC--(CCNMatthews - Jan. 18, 2005) - DIAGEM INC. (the "Company" or "Diagem") (TSX VENTURE:DGM) announces that it will undertake non brokered private placements of up to $2 million of units at $0.20 each. Each unit will consist of one common share of the Company and one common share purchase warrant. Each warrant will entitle the holder to purchase one common share of the Company at a price of $0.23 per share for a period of twenty-four months following the closing. Insiders of the Company will participate in these private placements.
Diagem also announces that it has granted a total of 3,150,000 options to purchase common shares in the Company to its directors and 1,050,000 options to purchase common shares to officers who are not directors of the Company. In addition, 750,000 options to purchase common shares have been granted to employees and a consultant of its Brazilian subsidiary. All options have an exercise price of $0.20 and an exercise period of five years.
For and on behalf of
DIAGEM INC.
"Mousseau Tremblay", Chairman and CEO
FOR FURTHER INFORMATION PLEASE CONTACT:
Diagem Inc.
Mousseau Tremblay
Chairman and CEO
(514) 866-6001 / (613) 347-2561
(514) 866-6193 (FAX)
Website: www.diagem.com
THE TSX VENTURE EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS PRESS RELEASE.
